These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
257 related items for PubMed ID: 18974065
1. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase. Hu XW, Meng D, Fang J. Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065 [Abstract] [Full Text] [Related]
2. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism. Franzen CA, Amargo E, Todorović V, Desai BV, Huda S, Mirzoeva S, Chiu K, Grzybowski BA, Chew TL, Green KJ, Pelling JC. Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984 [Abstract] [Full Text] [Related]
3. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ, Chen WK, Wang CJ, Lin WL, Tseng TH. Toxicol Appl Pharmacol; 2008 Jan 15; 226(2):178-91. PubMed ID: 17961621 [Abstract] [Full Text] [Related]
4. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Shi Q, Hjelmeland AB, Keir ST, Song L, Wickman S, Jackson D, Ohmori O, Bigner DD, Friedman HS, Rich JN. Mol Carcinog; 2007 Jun 15; 46(6):488-96. PubMed ID: 17219439 [Abstract] [Full Text] [Related]
5. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways. Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL, Yu CS, Lin ML, Yang JS, Kuo HM, Wu SH, Chung JG. Anticancer Res; 2010 Jun 15; 30(6):2135-43. PubMed ID: 20651362 [Abstract] [Full Text] [Related]
6. Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK). Sun T, Zhao N, Ni CS, Zhao XL, Zhang WZ, Su X, Zhang DF, Gu Q, Sun BC. Cancer Lett; 2009 Nov 28; 285(2):141-50. PubMed ID: 19482420 [Abstract] [Full Text] [Related]
7. Apigenin inhibits proliferation of ovarian cancer A2780 cells through Id1. Li ZD, Hu XW, Wang YT, Fang J. FEBS Lett; 2009 Jun 18; 583(12):1999-2003. PubMed ID: 19447105 [Abstract] [Full Text] [Related]
13. Focal adhesion kinase: a potential target in cancer therapy. van Nimwegen MJ, van de Water B. Biochem Pharmacol; 2007 Mar 01; 73(5):597-609. PubMed ID: 16997283 [Abstract] [Full Text] [Related]
17. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. Watanabe N, Takaoka M, Sakurama K, Tomono Y, Hatakeyama S, Ohmori O, Motoki T, Shirakawa Y, Yamatsuji T, Haisa M, Matsuoka J, Beer DG, Nagatsuka H, Tanaka N, Naomoto Y. Clin Cancer Res; 2008 Jul 15; 14(14):4631-9. PubMed ID: 18628478 [Abstract] [Full Text] [Related]
18. [The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer]. Fang J, Wei WN, Xia LH, Song SJ. Zhonghua Xue Ye Xue Za Zhi; 2004 Sep 15; 25(9):523-7. PubMed ID: 15569528 [Abstract] [Full Text] [Related]
19. Focal adhesion kinase promotes the aggressive melanoma phenotype. Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, Nickoloff BJ, Hendrix MJ. Cancer Res; 2005 Nov 01; 65(21):9851-60. PubMed ID: 16267008 [Abstract] [Full Text] [Related]